The RENOIR and AReSVi Trials: RSV & What Makes Vaccine Trials Different? | NEJM Resident 360
How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the… | NEJM Resident 360